Former executive alleges Takeda illegally promoted Actos to treat patients with prediabetes in Massachusetts whistleblower lawsuit
January 27th, 2016
Executives with Takeda Pharmaceutical, the manufacturer of Actos, admitted that they had paid physicians to prescribe the drug to patients …
Tags: Actos, bladder cancer, diebetes, False Claims Act, FDA, kickbacks, pre-diabetes, qui tam, Takeda, whistleblowers
Posted in Actos, HO&P Legal Blog, Qui Tam Litigation |